Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Increased non-specific inflammation observed in the skin of older adults negatively correlated with vitamin D sufficiency.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D3 replacement enhances antigen-specific immunity in older adults

Study design awaiting verification · Immunotherapy Advances · 2021

Original publication title

Vitamin D3 replacement enhances antigen-specific immunity in older adults

Emma S Chambers; Milica Vukmanovic-Stejic; Carolin T Turner; Barbara B Shih; Hugh Trahair; Gabriele Pollara; Evdokia Tsaliki; Malcolm Rustin; Tom C Freeman; Neil A Mabbott; Mahdad Noursadeghi; Adrian R Martineau; Arne N Akbar

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Immunology.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D3 replacement can boost antigen-specific immunity in older adults with sub-optimal vitamin D status.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).

Source: Objectives

Abstract: What methods does the paper describe?

Vitamin D insufficient older adults (n = 18) were administered 6400IU of vitamin D3/day orally for 14 weeks. Antigen-specific immunity to VZV was assessed by clinical score assessment of the injection site and transcriptional analysis of skin biopsies collected from challenged injection sites pre: and post-vitamin D3 replacement.

Source: Methods

Abstract: Results

We showed that older adults had reduced VZV-specific cutaneous immune response and increased non-specific inflammation as compared to young. Increased non-specific inflammation observed in the skin of older adults negatively correlated with vitamin D sufficiency. We showed that vitamin D3 supplementation significantly increased the response to cutaneous VZV antigen challenge in older adults. This enhancement was associated with a reduction in inflammatory monocyte infiltration with a concomitant enhancement of T cell recruitment to the site of antigen challenge in the skin.

Source: Results

Abstract: Conclusion

Vitamin D3 replacement can boost antigen-specific immunity in older adults with sub-optimal vitamin D status.

Source: Conclusion
Authors’ abstract

Summary

Introduction

Ageing is associated with increased number of infections, decreased vaccine efficacy and increased systemic inflammation termed inflammageing. These changes are reflected by reduced recall responses to varicella zoster virus (VZV) challenge in the skin of older adults. Vitamin D deficiency is more common in the old and has been associated with frailty and increased inflammation. In addition, vitamin D increases immunoregulatory mechanisms and therefore has the potential to inhibit inflammageing.

Objectives

We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).

Methods

Vitamin D insufficient older adults (n = 18) were administered 6400IU of vitamin D3/day orally for 14 weeks. Antigen-specific immunity to VZV was assessed by clinical score assessment of the injection site and transcriptional analysis of skin biopsies collected from challenged injection sites pre: and post-vitamin D3 replacement.

Results

We showed that older adults had reduced VZV-specific cutaneous immune response and increased non-specific inflammation as compared to young. Increased non-specific inflammation observed in the skin of older adults negatively correlated with vitamin D sufficiency. We showed that vitamin D3 supplementation significantly increased the response to cutaneous VZV antigen challenge in older adults. This enhancement was associated with a reduction in inflammatory monocyte infiltration with a concomitant enhancement of T cell recruitment to the site of antigen challenge in the skin.

Conclusion

Vitamin D3 replacement can boost antigen-specific immunity in older adults with sub-optimal vitamin D status.

Publication and source details

Original title: Vitamin D3 replacement enhances antigen-specific immunity in older adults

Emma S Chambers; Milica Vukmanovic-Stejic; Carolin T Turner; Barbara B Shih; Hugh Trahair; Gabriele Pollara; Evdokia Tsaliki; Malcolm Rustin; Tom C Freeman; Neil A Mabbott; Mahdad Noursadeghi; Adrian R Martineau; Arne N Akbar

Immunotherapy Advances · 2021

Correspondence: Emma S. Chambers, Centre for Immunobiology, Blizard Institute, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK. Email: emma.chambers@qmul.ac.uk© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Immunology.2020https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Medical Research Council10.13039/501100000265 Grand Challenge in Experimental Medicine MR/M003833/1 Barts Charity Lectureship Dermatrust LEO Skin Foundation LF-OC-19-000192 Biotechnology and Biological Sciences Research Council10.13039/501100000268 BBS/E/D/20002173 National Institute for Health Research University College London Hospitals Biomedical Research Centre

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T09:20:10.191248+00:00

DOI: 10.1093/immadv/ltaa008 · PMC9585673